June 28, 2017

Delafloxacin approval / Good example of a modern label

Dear All: FDA’s approval of delafloxacin (BAXDELA) was announced on 20 June 2017 and the label can be found here. In brief, delafloxacin is a fluoroquinolone with coverage for MRSA as well as key Gram-negative pathogens. The label is attached is worth reading as a good example of a modern label – reading closely will give

Read More »
Scroll to Top